课题基金 / 基金详情

Molecular mechanisms regulating the metabolic sensor soluble adenylyl cyclase and development of specific pharmacological modulators

Molecular mechanisms regulating the metabolic sensor soluble adenylyl cyclase and development of specific pharmacological modulators
调节代谢传感器可溶性腺苷酸环化酶的分子机制和特定药理调节剂的开发
批准号:
236401975
负责人:
Professor Dr. Clemens Steegborn
金额:
$0.0万
依托单位:
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2013
资助国家:
德国
项目状态:
已结题
起止时间:
2012-12-31 至 2020-12-31

项目摘要

项目成果

Professor Dr. Clemens Steegborn的其他基金

相似基金

相关文献

中文摘要
翻译
在哺乳动物中,第二信使cAMP由9个跨膜腺苷酸环化酶(tmAC)和1个可溶性AC (sAC)产生。它们都属于普遍存在的核苷酸环化酶III类,这是由一个保守的催化核心定义的。然而,sAC催化核心(sAC-cat)活性是由钙和代谢产物ATP和碳酸氢盐刺激的。全长sAC还包含一个难以表征的、sAC特异性的~1100个残基c端区域(CTR),该区域可能介导额外的调节机制。sAC参与多种生理功能,从神经细胞生长到胰岛素释放,被认为是皮肤癌和代谢性疾病的治疗靶点。我们通过生理和药理学配体及其CTR结构域研究sAC调节的分子机制,以了解细胞sAC的功能,并利用这些机制开发调节剂。在之前的资助期内,我们首次解决了sAC-cat及其与底物、产物、活化剂碳酸氢盐和抑制剂配合物的晶体结构。他们揭示了sAC催化及其通过碳酸氢盐和利用碳酸氢盐结合位点(BBS)的抑制剂(特别是新发现的变构抑制剂LRE1)调控的见解。我们现在开始了两种结构辅助方法,用于改善lre1相关抑制剂和开发用于碳酸氢盐依赖性激活的sAC激活剂和阻滞剂(碳酸氢盐阻滞剂)。首先,我们进行对接筛选,以确定不同sAC状态的新型BBS配体作为调制器候选体。其次,我们使用sAC配合物来设计可能改进的化合物衍生物。我们将通过活性和结合研究以及通过求解其sAC复合物的晶体结构来表征这些化合物。机制的见解将指导进一步的发展周期,有前途的化合物将在生理系统中表征。使用这种方法,我们已经确定了第一个碳酸氢盐阻断剂和有希望的sAC激活和抑制候选者。我们进一步开始表征sAC CTR,以获得sAC调控的新见解和新的调节靶点。我们首次从人类sAC和分枝杆菌同源物中鉴定出推测的CTR结构域的可溶性表达结构。我们计划确定更多的CTR结构域,并将对这些CTR结构域进行结构和生化表征:结构将揭示与具有已知功能的蛋白质的相似性,结合和活性分析将确定与sAC-cat和小分子配体的潜在相互作用以及CTR结构域及其复合物对sAC活性的影响。我们进一步计划寻找与CTR结构域相互作用的蛋白质,我们将通过诱变测试sAC调控的见解。总之,该项目有望提高我们对sAC和cAMP信号的理解,并为生理学研究和药物开发提供化合物。
英文摘要
In mammals, the second messenger cAMP is generated by nine trans-membrane adenylyl cyclases (tmAC) and one soluble AC (sAC). They all belong to the ubiquitous nucleotidyl cyclase Class III, which is defined by a conserved catalytic core. However, sAC catalytic core (sAC-cat) activity is uniquely stimulated by calcium and the metabolites ATP and bicarbonate. Full-length sAC further comprises a hardly characterized, sAC-specific ~1100 residues C-terminal region (CTR) that likely mediates additional regulation mechanisms. sAC contributes to various physiological functions, from nerve cell growth to insulin release, and is considered a therapeutic target for skin cancer and metabolic diseases.We study molecular mechanisms of sAC regulation by physiological and pharmacological ligands and by its CTR domains to understand cellular sAC functions and to exploit these mechanisms for modulator development. In the previous funding period, we solved first crystal structures of sAC-cat and its complexes with substrate, products, the activator bicarbonate, and inhibitors. They revealed insights in sAC catalysis and its regulation by bicarbonate and by inhibitors exploiting the bicarbonate binding site (BBS), in particular the newly discovered, allosteric inhibitor LRE1. We now started two structure-assisted approaches for improvement of LRE1-related inhibitors and for development of sAC activators and blockers for bicarbonate-dependent activation (bicarbonate blockers). First, we perform docking screens to identify novel BBS ligands for different sAC states as modulator candidates. Second, we use sAC complexes for designing potentially improved compound derivatives. We will characterize these compounds through activity and binding studies and by solving crystal structures of their sAC complexes. Mechanistic insights will guide further development cycles, and promising compounds will be characterized in physiological systems. Using this approach we already identified first bicarbonate blockers and promising candidates for sAC activation and inhibition. We further started to characterize the sAC CTR to obtain new insights in sAC regulation and novel target sites for modulation. We identified first soluble expression constructs for putative CTR domains from human sAC and a mycobacterial homolog. We plan to identify additional ones and will characterize these CTR domains structurally and biochemically: Structures will reveal similarities to proteins with known functions, and binding and activity assays will identify potential interactions with sAC-cat and small-molecule ligands and effects of CTR domains and their complexes on sAC activity. We further plan to search for proteins that interact with CTR domains, and we will test insights in sAC regulation via mutagenesis. Taken together, the project promises to improve our understanding of sAC and cAMP signaling and to provide compounds for physiological studies and drug development.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular mechanisms of physiological Sirtuin 1 regulation and targeting these mechanisms with drugs
  • 批准号:
    277644855
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2015
  • 负责人:
    Professor Dr. Clemens Steegborn
  • 依托单位:
Structural and biochemical characterization of Class I and Class III adenylyl cyclases from microbial pathogens
  • 批准号:
    161714577
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2009
  • 负责人:
    Professor Dr. Clemens Steegborn
  • 依托单位:
Molecular mechanisms of signal transduction by the mitochondrial life-span regulators p66Shc and Sirtuins
Molecular regulation mechanisms of receptor guanylyl cyclases
  • 批准号:
    54247893
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2007
  • 负责人:
    Professor Dr. Clemens Steegborn
  • 依托单位:
国内基金
海外基金
Exploring the Intrinsic Mechanisms of CEO Turnover and Market
  • 批准号:
    --
  • 项目类别:
    外国学者研究基金
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    HAOFEI Z
  • 依托单位:
Exploring the Intrinsic Mechanisms of CEO Turnover and Market Reaction: An Explanation Based on Information Asymmetry
  • 批准号:
    W2433169
  • 项目类别:
    外国学者研究基金项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    HAOFEI ZHANG
  • 依托单位:
Erk1/2/CREB/BDNF通路在CSF1R相关性白质脑病致病机制中的作用研究
  • 批准号:
    82371255
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    曹立
  • 依托单位:
Foxc2介导Syap1/Akt信号通路调控破骨/成骨细胞分化促进颞下颌关节骨关节炎的机制研究
  • 批准号:
    82370979
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    张善勇
  • 依托单位: